ID: ALA126013

Max Phase: Preclinical

Molecular Formula: C7H9N3O2

Molecular Weight: 167.17

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=CCNc1cc(O)nc(O)n1

Standard InChI:  InChI=1S/C7H9N3O2/c1-2-3-8-5-4-6(11)10-7(12)9-5/h2,4H,1,3H2,(H3,8,9,10,11,12)

Standard InChI Key:  JEBCEODODJJXLY-UHFFFAOYSA-N

Associated Targets(non-human)

DNA topoisomerase III 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 167.17Molecular Weight (Monoisotopic): 167.0695AlogP: 0.49#Rotatable Bonds: 3
Polar Surface Area: 78.27Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.74CX Basic pKa: 1.49CX LogP: 1.51CX LogD: 1.50
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.57Np Likeness Score: -1.08

References

1. Wright GE, Brown NC..  (1980)  Inhibitors of Bacillus subtilis DNA polymerase III. 6-Anilinouracils and 6-(alkylamino)uracils.,  23  (1): [PMID:6767030] [10.1021/jm00175a007]

Source